產品詳情
簡單介紹：
Anti-DPY19L1抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-DPY19L1抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-DPY19L1
Cat. Number:
Anti-DPY19L1抗體KL-8289R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Dpy-19 (dumpy-19), is a 683 amino acid C. elegans protein that is required to orient the neuroblasts QL and QR correctly on the anterior/posterior axis. Dpy-19 is expressed highly in dorsal hyp7 cells, ventral P Anti-DPY19L1抗體cells and lateral V cells, and dorsal and ventral body muscle cells. DPY19L1 (Dpy-19-like protein 1), also known as KIAA0877, is a 675 amino acid multi-pass membrane protein that belongs to the Dpy-19 family. DPY19L1 is expressed as two isoforms produced by alternative splicing and is encoded by a gene mapping to human chromosome 7, which encodes over 1,000 genes and makes up about 5% of the human genome. Diseases associated with chromosome 7 include Osteogenesis imperfecta, Pendred syndrome, Lissencephaly, Citrullinemia and Shwachman-Diamond syndrome. The deletion of a portion of the q arm of chromosome 7 is associated with Williams-Beuren syndrome, a condition characterized by mild mental retardation, an unusual comfort and friendliness with strangers and an elfin appearance. Deletions of portions of the q arm of chromosome 7 are also seen in a number of myeloid disorders including cases of acute myelogenous leukemia and myelodysplasia.
Also known as:
D19L1_HUMAN; Dpy 19 like Anti-DPY19L1抗體1 (C. elegans); Dpy 19 like protein 1; Dpy-19-like protein 1; DPY19L1; GA0500; KIAA0877; Protein dpy 19 homolog 1; Protein dpy-19 homolog 1; Protein dpy19 homolog 1.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Zebrafish, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human DPY19L1.
●
Predicted Molecular Weight: 77kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-DPY19L1抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions mustAnti-DPY19L1抗體 be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions mustAnti-DPY19L1抗體 be determined by the end user.
kl096Po01 巨噬細胞炎性蛋白3β(MIP3β)多克隆抗體 Polyclonal Antibody to Macrophage Inflammatory Protein 3 Beta (MIP3b)
kl096Ra01 巨噬細胞炎性蛋白3β(MIP3β)多克隆抗體 Polyclonal Antibody to Macrophage Inflammatory Protein 3 Beta (MIP3b)
kl097Bo01 基質金屬蛋白酶1(MMP1)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 1 (MMP1)
kl097Eq01 基質金屬蛋白酶1(MMP1)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 1 (MMP1)
kl097Hu01 基質金屬蛋白酶1(MMP1)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 1 (MMP1)
kl097Mu01 基質金屬蛋白酶1(MMP1)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 1 (MMP1)
kl097Ov01 基質金屬蛋白酶1(MMP1)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 1 (MMP1)
kl097Po01 基質金屬蛋白酶1(MMP1)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 1 (MMP1)
kl097Ra01 基質金屬蛋白酶1(MMP1)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 1 (MMP1)
kl097Rb51 基質金屬蛋白酶1(MMP1)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 1 (MMP1)
kl098Hu01 基質金屬蛋白酶10(MMP10)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 10 (MMP10)
kl098Mu01 基質金屬蛋白酶10(MMP10)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 10 (MMP10)
kl098Po01 基質金屬蛋白酶10(MMP10)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 10 (MMP10)
kl098Ra01 基質金屬蛋白酶10(MMP10)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 10 (MMP10)
kl099Bo01 基質金屬蛋白酶13(MMP13)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 13 (MMP13)
kl099Ca01 基質金屬蛋白酶13(MMP13)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 13 (MMP13)
kl099Cp01 基質金屬蛋白酶13(MMP13)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 13 (MMP13)
kl099Eq01 基質金屬蛋白酶13(MMP13)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 13 (MMP13)
